ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,202, issued on Oct. 20, was assigned to University of Pittsburgh-Of the Commonwealth System of Higher Education (Pittsburgh) and The Curators of the University of Missouri (Columbia, Mo.).
"Radionuclide and near-infrared dye conjugated antibody for detection of GD2-positive cancer" was invented by Marcus Malek (Pittsburgh), Gary Kohanbash (Pittsburgh), Wilson Barry Edwards (Columbia, Mo.) and Lauren Rosenblum (Pittsburgh).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is an antibody-conjugate comprising a monoclonal antibody that specifically binds to GD2 and comprises a heavy chain and a light chain comprising heavy and light chain ...